Anfield Capital Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Anfield Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $1,805 - $1,986	2 New	2 $1,000
Q4 2022 Feb 01, 2023	SELL	$705.89 - $766.39 $161,648 - $175,503	-229 Reduced 50.11%	228 $164,000
Q3 2022 Nov 09, 2022	BUY	$573.97 - $724.32 $9,183 - $11,589	16 Added 3.63%	457 $315,000
Q2 2022 Aug 09, 2022	BUY	$548.35 - $738.84 $35,094 - $47,285	64 Added 16.98%	441 $261,000
Q1 2022 May 13, 2022	BUY	$595.12 - $698.43 $116,643 - $136,892	196 Added 108.29%	377 $263,000
Q4 2021 Feb 03, 2022	BUY	$543.48 - $670.97 $89,674 - $110,710	165 Added 1031.25%	181 $114,000
Q3 2021 Nov 04, 2021	SELL	$574.03 - $680.96 $1,148 - $1,361	-2 Reduced 11.11%	16 $10,000
Q2 2021 Aug 03, 2021	BUY	$472.8 - $558.54 $8,510 - $10,053	18 New	18 $10,000

1,529

82.7M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Anfield Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Anfield Capital Management, LLC with notifications on news.